1. Home
  2. SYBX vs GLXG Comparison

SYBX vs GLXG Comparison

Compare SYBX & GLXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • GLXG
  • Stock Information
  • Founded
  • SYBX N/A
  • GLXG 2013
  • Country
  • SYBX United States
  • GLXG Hong Kong
  • Employees
  • SYBX N/A
  • GLXG N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • GLXG
  • Sector
  • SYBX Health Care
  • GLXG
  • Exchange
  • SYBX Nasdaq
  • GLXG NYSE
  • Market Cap
  • SYBX 13.6M
  • GLXG 11.1M
  • IPO Year
  • SYBX N/A
  • GLXG 2024
  • Fundamental
  • Price
  • SYBX $1.26
  • GLXG $0.55
  • Analyst Decision
  • SYBX
  • GLXG
  • Analyst Count
  • SYBX 0
  • GLXG 0
  • Target Price
  • SYBX N/A
  • GLXG N/A
  • AVG Volume (30 Days)
  • SYBX 7.8K
  • GLXG 174.0K
  • Earning Date
  • SYBX 08-07-2025
  • GLXG 08-16-2025
  • Dividend Yield
  • SYBX N/A
  • GLXG N/A
  • EPS Growth
  • SYBX N/A
  • GLXG N/A
  • EPS
  • SYBX 0.21
  • GLXG N/A
  • Revenue
  • SYBX N/A
  • GLXG $3,711,233.00
  • Revenue This Year
  • SYBX N/A
  • GLXG N/A
  • Revenue Next Year
  • SYBX N/A
  • GLXG N/A
  • P/E Ratio
  • SYBX $5.82
  • GLXG N/A
  • Revenue Growth
  • SYBX N/A
  • GLXG N/A
  • 52 Week Low
  • SYBX $0.90
  • GLXG $0.39
  • 52 Week High
  • SYBX $1.88
  • GLXG $16.93
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 52.81
  • GLXG N/A
  • Support Level
  • SYBX $1.17
  • GLXG N/A
  • Resistance Level
  • SYBX $1.27
  • GLXG N/A
  • Average True Range (ATR)
  • SYBX 0.04
  • GLXG 0.00
  • MACD
  • SYBX -0.01
  • GLXG 0.00
  • Stochastic Oscillator
  • SYBX 40.00
  • GLXG 0.00

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About GLXG GALAXY PAYROLL GROUP LTD

Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.

Share on Social Networks: